Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinical Trials

Set Alert for Clinical Trials

Starts & Stops: Mercator Looking To Leap Into New Indications For Bullfrog Micro-Infusion Drug-Delivery

Starts & Stops is a regular feature highlighting Medtech Insight's monthly editors' picks of noteworthy medtech clinical trial announcements, initiations, completions, and suspensions. This month's edition, covering November, is led by a major milestone for Mercator Medsystems, developer of the Bullfrog micro-infusion catheter.

Clinical Trials Starts & Stops Research & Development
Advertisement

Latest From Clinical Trials

Starts & Stops: 2017 Finishes With Progress For Edwards, Stalled Trials For Boston Scientific

Starts & Stops is a regular feature highlighting Medtech Insight's monthly picks of noteworthy clinical trial announcements, initiations, completions, and suspensions. The list for December is headlined by announcements on Edwards' transcatheter valve technologies. Meanwhile, MValve, a company Boston Scientific has invested in, is not going forward with a planned trial of its MValve dock device with Boston Scientific's Lotus valve now that Lotus is off the market.

Clinical Trials Starts & Stops

MRI And Cardiac-Rhythm Devices: A Match Made In Medicare

A proposed coverage policy from the US Centers for Medicare and Medicaid Services would not only cover magnetic resonance imaging for patients with an implanted cardiac rhythm management device with an FDA-approved indication for MRI-compatibility, but will also cover MRI in patients with devices without that FDA labeling in certain circumstances.

United States Clinical Trials

QUOTED. Jan. 16, 2018. Kelly Londy.

Check out what Lumicell CEO Kelly Londy had to say about why the device-maker is developing its LUM system to treat prostate, colorectal, esophageal and pancreatic cancers.
Quoted Clinical Trials

New EU Devices Regulation Lacking As A Safety And Effectiveness Check, German Study Claims

Even though the new EU Medical Device Regulation marks a “very important advancement,” it still falls short when it comes to requirements on generating clinical evidence, according to a study conducted in Germany.

Europe Clinical Trials

Swedish Tinnitus Patch Rings In Positive Placebo-Controlled Data

Swedish company Sensori received a ringing endorsement from results of a clinical placebo study evaluating the use of its Antinitus patch to treat tinnitus. Results from the study were published in the scientific journal The International Tinnitus Journal.

Ear Innovation

Device Debut: Zimmer Biomet's Sidus Stemless Shoulder Will Take On Wright's Simpliciti

US FDA cleared the Sidus total shoulder arthroplasty system for patients with "good bone stock" who have osteoarthritis, posttraumatic arthrosis, focal avascular necrosis of the humeral head, or a previous shoulder surgery that does not compromise the fixation. The company is planning to launch it in the US by the end of the quarter.

United States Innovation

Obesity Firm Allurion Preps For Global Expansion, US Trial With Changes At Top

Intragastric balloon-maker Allurion is making some major changes in its executive suite to support its plan to expand its market reach.

Clinical Trials Business Strategies

San Antonio Breast Cancer Symposium: New Diagnostics From Myriad, Lumicell, Agendia

Myriad Genetics, Lumicell, and Agendia were among the companies with diagnostic technologies featured in the scientific presentations at the recent San Antonio Breast Cancer Symposium. New trials show that Myriad's EndoPredict can help identify patients who should not have preoperative chemotherapy. New Phase II data support Lumicell's LUM system for guiding excision of residual tumor and preventing cancer recurrence. Agendia's MammaPrint test proved cost-effective in the MINDACT trial.

Clinical Trials Research & Development

FDA Recruits Patients, Advocates For Development Forum

In another step to make its work more patient-friendly, US FDA is recruiting members for a patient advocacy group that will focus on medical product development.

Medical Device Clinical Trials
See All
UsernamePublicRestriction

Register